IBBJ News and Press, Defiance Nasdaq Junior Biotechnology ETF From 12/26/20

Recent positive developments in COVID-19 vaccines have spurred a wave of market exuberance, lifting share prices of biotech companies at the forefront of the vaccine race. COVID-19 and the urgency to find a cure have opened up opportunities, making the biotech sector a prospective spa...

Annualized 2020 Return Since IBBJ’s Launch is 100.87% vs Nasdaq Biotech TR Index 5.77% IBBJ 20.83% (since inception) vs. Nasdaq Biotechnology TR Index 1.53% About Defiance: Founded in 2018, Defiance ETFs is an exchange-traded funds (ETFs) sponsor and registered in...